Cargando…

An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma

Melanoma is the most aggressive and lethal type of skin cancer, with a poor prognosis because of the potential for metastatic spread. The aim was to develop innovative powder formulations for the treatment of metastatic melanoma based on micro- and nanocarriers containing 5-fluorouracil (5FU) for pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zatta, Kelly Cristine, Frank, Luiza A., Reolon, Luciano Antonio, Amaral-Machado, Lucas, Egito, Eryvaldo S. T., Gremião, Maria Palmira Daflon, Pohlmann, Adriana Raffin, Guterres, Silvia S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5853707/ https://www.ncbi.nlm.nih.gov/pubmed/29385692 http://dx.doi.org/10.3390/nano8020075

Ejemplares similares

Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
por: Fonseca-Santos, Bruno, et al.
Publicado: (2015)

Nanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A Review
por: Rigon, Roberta Balansin, et al.
Publicado: (2015)

Ionic Cross-Linking as a Strategy to Modulate the Properties of Oral Mucoadhesive Microparticles Based on Polysaccharide Blends
por: Boni, Fernanda Isadora, et al.
Publicado: (2021)

Buccal Bullfrog (Rana catesbeiana Shaw) Oil Emulsion: A Mucoadhesive System Intended for Treatment of Oral Candidiasis
por: Moreira-Oliveira, Susiane S., et al.
Publicado: (2018)

Design, characterization, and biological evaluation of curcumin-loaded surfactant-based systems for topical drug delivery
por: Fonseca-Santos, Bruno, et al.
Publicado: (2016)

Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations
por: Miyamoto, Kahori, et al.
Publicado: (2022)

Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation
por: Sibum, Imco, et al.
Publicado: (2019)

Spray Dried Formulations for Inhalation—Meaningful Characterisation of Powder Properties
por: Jüptner, Angelika, et al.
Publicado: (2019)

Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022)

Data of characterization and related assays of lipid-core nanocapsule formulations and their hydrolysis mechanism
por: Calgaroto, Selma, et al.
Publicado: (2018)

Hydrogels containing redispersible spray-dried melatonin-loaded nanocapsules: a formulation for transdermal-controlled delivery
por: Hoffmeister, Cristiane RD, et al.
Publicado: (2012)

Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery
por: Rashid, Md Abdur, et al.
Publicado: (2019)

Puerarin dry powder inhaler formulations for pulmonary delivery: Development and characterization
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy
por: Shao, Zitong, et al.
Publicado: (2021)

Progress on Thin Film Freezing Technology for Dry Powder Inhalation Formulations
por: Pardeshi, Sagar R., et al.
Publicado: (2022)

Semiochemical delivery systems based on natural polymers to attract sand flies (Diptera: Psychodidae)
por: Bueno, Ana Carolina, et al.
Publicado: (2023)

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

Copaiba Oil-Loaded Polymeric Nanocapsules: Production and In Vitro Biosafety Evaluation on Lung Cells as a Pre-Formulation Step to Produce Phytotherapeutic Medicine
por: Rodrigues, Victor M., et al.
Publicado: (2023)

Development and evaluation of Chitosan nanoparticles based dry powder inhalation formulations of Prothionamide
por: Debnath, Sujit Kumar, et al.
Publicado: (2018)

POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
por: Restani, Rita B., et al.
Publicado: (2018)

The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics
por: Abiona, Olaitan, et al.
Publicado: (2022)

Inhalable microparticles as drug delivery systems to the lungs in a dry powder formulations
por: Knap, Karolina, et al.
Publicado: (2022)

Hesperetin-loaded lipid-core nanocapsules in polyamide: a new textile formulation for topical drug delivery
por: Menezes, Paula dos Passos, et al.
Publicado: (2017)

Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
por: Rashid, Md Abdur, et al.
Publicado: (2021)

Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?
por: Amaral-Machado, Lucas, et al.
Publicado: (2021)

Use of Natural Products in Asthma Treatment
por: Amaral-Machado, Lucas, et al.
Publicado: (2020)

Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
por: Salem, HF, et al.
Publicado: (2011)

Development of an Inhaled Sustained Release Dry Powder Formulation of Salbutamol Sulphate, an Antiasthmatic Drug
por: Kumaresan, C., et al.
Publicado: (2016)

Formulation and In Vitro and In Silico Characterization of “Nano-in-Micro” Dry Powder Inhalers Containing Meloxicam
por: Party, Petra, et al.
Publicado: (2021)

Hydroxyethylcellulose-Based Hydrogels Containing Liposomes Functionalized with Cell-Penetrating Peptides for Nasal Delivery of Insulin in the Treatment of Diabetes
por: Von Zuben, Eliete de Souza, et al.
Publicado: (2022)

Organic Nanocarriers for Bevacizumab Delivery: An Overview of Development, Characterization and Applications
por: Alves, Aline de Cristo Soares, et al.
Publicado: (2021)

Inhalation of a Dry Powder Ciprofloxacin Formulation in Healthy Subjects: A Phase I Study
por: Stass, Heino, et al.
Publicado: (2013)

Pulmonary delivery of liposomal dry powder inhaler formulation for effective treatment of idiopathic pulmonary fibrosis
por: Chennakesavulu, S., et al.
Publicado: (2018)

A Critical Review on Emerging Trends in Dry Powder Inhaler Formulation for the Treatment of Pulmonary Aspergillosis
por: Cheng, Shen Nam, et al.
Publicado: (2020)

State of the Art in Capsule-Based Dry Powder Inhalers: Deagglomeration Techniques and the Consequences for Formulation Aerosolization
por: Groß, Roman, et al.
Publicado: (2022)

Inhalable Nanoparticle-based Dry Powder Formulations for Respiratory Diseases: Challenges and Strategies for Translational Research
por: Chan, Ho Wan, et al.
Publicado: (2023)

Stability of Inhaled Ciprofloxacin-Loaded Poly(2-ethyl-2-oxazoline) Nanoparticle Dry Powder Inhaler Formulation in High Stressed Conditions
por: Sabuj, Mohammad Zaidur Rahman, et al.
Publicado: (2022)

Data of PCL-b-P(MMA-DMAEMA)(2) characterization and related assays
por: Franco, Camila, et al.
Publicado: (2017)

Chitosan gel containing polymeric nanocapsules: a new formulation for vaginal drug delivery
por: Frank, Luiza A, et al.
Publicado: (2014)

The effect of ethanol on the habit and in vitro aerodynamic results of dry powder inhalation formulations containing ciprofloxacin hydrochloride
por: Benke, Edit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_22ui08k64jprgudr3kfbn00d5i